SCHEMBL4757189

SCHEMBL4757189

Cc1ccc(C(=O)Nc2ncc(S(C)(=O)=O)s2)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 1/20 0.48
STAT3 P40763 2/20 0.47
RAB9A P51151 7/20 0.46
NPC1 O15118 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
CYP2C19 P33261 2/20 0.45
PPARG P37231 2/20 0.45
ALDH1A1 P00352 1/20 0.45
NCOA2 Q15596 1/20 0.45
NCOA1 Q15788 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
HPGD P15428 4/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
GRM4 Q14833 2/20 0.43
AVPR2 P30518 1/20 0.43
GPR27 Q9NS67 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757157 0.88 STAT3 (0.49) FFAR2STAT3RAB9ANPC1SMN1; SMN2
SCHEMBL4755924 0.87 STAT3 (0.63) FFAR2STAT3RAB9ANPC1SMN1; SMN2
SCHEMBL4755857 0.86 STAT3 (0.47) FFAR2STAT3RAB9ANPC1SMN1; SMN2
SCHEMBL4757200 0.84 FFAR2 (0.47) FFAR2RAB9ANPC1MEN1KMT2A
SCHEMBL4755898 0.84 STAT3 (0.63) FFAR2STAT3RAB9ANPC1MEN1
SCHEMBL4756975 0.83 FFAR2 (0.48) FFAR2STAT3RAB9ANPC1SMN1; SMN2
SCHEMBL10114555 0.83 FFAR2 (0.44) FFAR2STAT3RAB9ANPC1SMN1; SMN2
SCHEMBL4757155 0.80 NPC1 (0.59) FFAR2RAB9ANPC1SMN1; SMN2MEN1
SCHEMBL4757105 0.80 FFAR2 (0.44) FFAR2STAT3RAB9ANPC1SMN1; SMN2
SCHEMBL4757204 0.79 FFAR2 (0.44) FFAR2RAB9ANPC1SMN1; SMN2RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC FFAR2 4045/4885STAT3 63/4885RAB9A 1694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.